| Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery E Roger, F Lagarce, E Garcion, JP Benoit Nanomedicine 5 (2), 287-306, 2010 | 338 | 2010 |
| Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded lipid nanocapsules S Peltier, JM Oger, F Lagarce, W Couet, JP Benoît Pharmaceutical research 23, 1243-1250, 2006 | 338 | 2006 |
| Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis E Roger, F Lagarce, E Garcion, JP Benoit Journal of controlled release 140 (2), 174-181, 2009 | 281 | 2009 |
| Toward an effective strategy in glioblastoma treatment. Part I: resistance mechanisms and strategies to overcome resistance of glioblastoma to temozolomide K Messaoudi, A Clavreul, F Lagarce Drug discovery today 20 (7), 899-905, 2015 | 270 | 2015 |
| Development and characterization of a novel lipid nanocapsule formulation of Sn38 for oral administration E Roger, F Lagarce, JP Benoit European journal of pharmaceutics and biopharmaceutics 79 (1), 181-188, 2011 | 140 | 2011 |
| Injectable nanomedicine hydrogel for local chemotherapy of glioblastoma after surgical resection C Bastiancich, J Bianco, K Vanvarenberg, B Ucakar, N Joudiou, B Gallez, ... Journal of controlled release 264, 45-54, 2017 | 137 | 2017 |
| Lauroyl-gemcitabine-loaded lipid nanocapsule hydrogel for the treatment of glioblastoma FD C Bastiancich, K Vanvarenberg, B Ucakar, M Pitorre, G Bastiat, F Lagarce ... Journal of Controlled Release 225, 283-293, 2016 | 125 | 2016 |
| The gastrointestinal stability of lipid nanocapsules E Roger, F Lagarce, JP Benoit International journal of pharmaceutics 379 (2), 260-265, 2009 | 123 | 2009 |
| Lipid nanocapsules: ready-to-use nanovectors for the aerosol delivery of paclitaxel J Hureaux, F Lagarce, F Gagnadoux, L Vecellio, A Clavreul, E Roger, ... European journal of pharmaceutics and biopharmaceutics 73 (2), 239-246, 2009 | 120 | 2009 |
| Models for drug absorption from the small intestine: where are we and where are we going? PA Billat, E Roger, S Faure, F Lagarce Drug discovery today 22 (5), 761-775, 2017 | 119 | 2017 |
| Combined anti-Galectin-1 and anti-EGFR siRNA-loaded chitosan-lipid nanocapsules decrease temozolomide resistance in glioblastoma: in vivo evaluation F Danhier, K Messaoudi, L Lemaire, JP Benoit, F Lagarce International journal of pharmaceutics 481 (1-2), 154-161, 2015 | 106 | 2015 |
| How to design the surface of peptide-loaded nanoparticles for efficient oral bioavailability? H Malhaire, JC Gimel, E Roger, JP Benoît, F Lagarce Advanced drug delivery reviews 106, 320-336, 2016 | 99 | 2016 |
| Mucus models to evaluate nanomedicines for diffusion AC Groo, F Lagarce Drug discovery today 19 (8), 1097-1108, 2014 | 90 | 2014 |
| Fate of paclitaxel lipid nanocapsules in intestinal mucus in view of their oral delivery AC Groo, P Saulnier, JC Gimel, J Gravier, C Ailhas, JP Benoit, F Lagarce International journal of nanomedicine, 4291-4302, 2013 | 87 | 2013 |
| Toxicological Study and Efficacy of Blank and Paclitaxel-Loaded Lipid Nanocapsules After i.v. Administration in Mice J Hureaux, F Lagarce, F Gagnadoux, MC Rousselet, V Moal, T Urban, ... Pharmaceutical research 27, 421-430, 2010 | 75 | 2010 |
| Reciprocal competition between lipid nanocapsules and P-gp for paclitaxel transport across Caco-2 cells E Roger, F Lagarce, E Garcion, JP Benoit European Journal of Pharmaceutical Sciences 40 (5), 422-429, 2010 | 72 | 2010 |
| Gemcitabine and glioblastoma: challenges and current perspectives C Bastiancich, G Bastiat, F Lagarce Drug discovery today 23 (2), 416-423, 2018 | 62 | 2018 |
| Baclofen-loaded microspheres in gel suspensions for intrathecal drug delivery: in vitro and in vivo evaluation F Lagarce, N Faisant, JC Desfontis, L Marescaux, F Gautier, J Richard, ... European journal of pharmaceutics and biopharmaceutics 61 (3), 171-180, 2005 | 61 | 2005 |
| Nanomedicine in drug delivery A Kumar, HM Mansour, A Friedman, ER Blough, CRC Press CRC Press, 2013 | 60 | 2013 |
| Development and in vitro evaluation of a novel lipid nanocapsule formulation of etoposide B Saliou, O Thomas, N Lautram, A Clavreul, J Hureaux, T Urban, ... European Journal of Pharmaceutical Sciences 50 (2), 172-180, 2013 | 59 | 2013 |
Veronique PreatProfesseur, Université catholique de Louvain在 uclouvain.be 的电子邮件经过验证
